R. Gangaraju

发表

Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2 a Use in a Patient With Polycythemia

J. Prchal, Soo Jin Kim, Jing-fei Dong, 2017 .

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.

M. Marques, X. Zheng, W. Cao, 2019, Blood advances.

Race, Rituximab, and Relapse in TTP.

Gustaaf G. de Ridder, K. McCrae, Shruti Chaturvedi, 2022, Blood.

Upshaw-Schulman syndrome and pregnancy: successful management with plasma infusions

G. Rodgers, R. Gangaraju, 2016, Annals of Hematology.

Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell Disease

M. Scully, M. Marques, Radhika Gangaraju, 2022, Journal of clinical medicine.

Association between peripheral blood cytopenia and cancer mortality: A race‐specific risk factor for cancer death

T. Akinyemiju, Insu Koh, N. Zakai, 2022, Cancer medicine.

Peripheral Blood Cytopenia and Risk of Cardiovascular Disease and Mortality

S. Bhatia, M. Cushman, Insu Koh, 2021, Journal of the American Heart Association.

In reply: Complete blood cell count March 2019

M. Marques, V. Reddy, Radhika Gangaraju, 2019, Cleveland Clinic Journal of Medicine.

Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model

S. Bhatia, D. Weisdorf, M. Arora, 2021, Blood advances.

Three neglected numbers in the CBC: The RDW, MPV, and NRBC count

M. Marques, V. Reddy, Jori E. May, 2019, Cleveland Clinic Journal of Medicine.

Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials

G. Sonpavde, C. Morgan, R. Paluri, 2019, Oncology reviews.

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.

J. Prchal, T. Tashi, K. Sundar, 2020, Blood advances.

Current Practice and Clinical Utility of Thrombophilia Testing in Hospitalized Patients with Acute Ischemic Stroke.

K. Martin, Chen Lin, Jori E. May, 2020, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Regulation of erythropoiesis after normoxic return from chronic sustained and intermittent hypoxia.

J. Prchal, K. Sundar, Jihyun Song, 2017, Journal of applied physiology.

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

J. Zwicker, M. Lim, L. Baumann Kreuziger, 2021, Journal of thrombosis and haemostasis : JTH.

Advanced therapies and extracorporeal membrane oxygenation for the management of high-risk pulmonary embolism.

F. Klok, Radhika Gangaraju, R. Gangaraju, 2020, Hematology. American Society of Hematology. Education Program.

Venous‐thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma

S. Bhatia, K. Kenzik, Radhika Gangaraju, 2022, Cancer.

Congenital and acquired disorders of secondary hemostasis

R. Paschal, M. Marques, Richard C Godby, 2021, Annals of Blood.

5599228 PITFALLS IN DIAGNOSING THROMBOTIC THROMBOCYTOPENIC PURPURA IN SICKLE CELL DISEASE

M. Scully, D. Tsitsikas, M. B. Marques, 2023, HemaSphere.

Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantation

S. Bhatia, D. Weisdorf, M. Arora, 2019, Cancer.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

R. Lorenz, E. Staley, M. Marques, 2018, Haematologica.

Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis

C. Lundby, T. Ganz, K. Indrák, 2023, American journal of hematology.

Rare complication of treated immune thrombocytopenia

K. Smock, N. Heikal, Radhika Gangaraju, 2017, American journal of hematology.

Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients

S. Bhatia, D. Weisdorf, Yanjun Chen, 2023, JACC: CardioOncology.

Venous thromboembolism in Autologous Blood or Marrow Transplant Survivors: A report from Blood or Marrow Transplant Survivor Study.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies

M. Marques, V. Reddy, Radhika Gangaraju, 2016, Southern medical journal.

Thrombotic Thrombocytopenic Purpura Associated With Pegylated Interferon Alfa-2a Use in a Patient With Polycythemia Vera.

J. Prchal, Soo Jin Kim, Jing-fei Dong, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study

S. Bhatia, D. Weisdorf, M. Arora, 2019, British journal of haematology.

Challenges in the diagnosis of thrombotic thrombocytopenic purpura

Jori E. May, R. Siniard, R. Gangaraju, 2023, Expert review of hematology.

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

S. Bhatia, D. Weisdorf, M. Arora, 2019, Blood.

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

A. Presson, Shruti Chaturvedi, R. Kasthuri, 2024, Research and practice in thrombosis and haemostasis.